An innovative hub of pharmaceutical manufacturers

The sustainable success of the pharmaceuticals industry in Berlin-Brandenburg is based on a history of innovative products going back to the 19th century. The industry benefits from an excellent scientific and clinical environment as well as proximity to the decision-makers of the German health care system.

The geographical location of the German capital region enables good access to Western, Central and Eastern European markets. Global players such as Bausch + Lomb, Bayer, Berlin-Chemie (Menarini), Daiichi Sankyo, Klosterfrau, Pfizer, Sanofi and Takeda as well as more than 20 medium-sized pharmaceutical companies are based in Berlin-Brandenburg. They employ around 12,300 people.

The industry benefits from

• an excellent scientific and clinical environment
• the biotech expertise in the region
• proximity to the decision-makers for the German healthcare system
• the central geographical location of the German capital region with good access to Western, Central, and Eastern European markets
• the close connection between research, development, and clinical practice
• well established translational research
• excellent infrastructure for technology transfer
• numerous options for clinical trials

With a large and diverse patient population and 151 hospitals, the Berlin-Brandenburg region makes all types of clinical research projects possible.